Background
Inclusion of a 12-lead electrocardiogram in the preparticipation screening of young athletes is controversial in large part due to concerns over cost-effectiveness.
Objective
To evaluate the cost-effectiveness of electrocardiography plus cardiac-focused history and physical and history and physical for preparticipation screening.
Design
Decision analysis cost-effectiveness model.
Data Sources
Published epidemiologic and preparticipation screening data, vital statistics, other publicly available data.
Target Population
High school and college competitive athletes ages 14 to 22
Time Horizon
Lifetime.
Perspective
Societal.
Interventions
Non-participation in competitive athletic activity and disease-specific treatment for identified athletes with heart disease.
Outcome Measures
Incremental health care cost per life year gained.
Results of Base-Case Analysis
The addition of electrocardiography to pre-participation screening saves 2.06 life years per 1000 athletes at an incremental total cost of $89 per athlete, yielding a cost-effectiveness ratio of $42,900 per life year saved (95% confidence interval, $21,200–71,300) when compared with cardiac-focused history and physical alone and saves 2.6 life years per 1000 athletes screened and costs $199 per athlete, yielding a cost-effectiveness ratio of $76,100 per life year saved ($62,400–130,000) when compared with no screening.
Results of Sensitivity Analysis
Results are sensitive to the relative risk reduction associated with non-participation and the cost of initial screening.
Limitations
Effectiveness data is derived from one major European study. Patterns of sudden death etiology may vary among countries.
Conclusions
Screening young athletes with a 12-lead electrocardiogram plus cardiovascular-focused history and physical may be cost effective.